Christopher Y Chai - Net Worth and Insider Trading
Christopher Y Chai Net Worth
The estimated net worth of Christopher Y Chai is at least $684,442 dollars as of 2024-09-20. Christopher Y Chai is the CFO of Principia Biopharma Inc and owns about 6,841 shares of Principia Biopharma Inc (PRNB) stock worth over $684,442. Details can be seen in Christopher Y Chai's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher Y Chai has not made any transactions after 2020-08-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher Y Chai
Christopher Y Chai Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher Y Chai owns 3 companies in total, including Principia Biopharma Inc (PRNB) , Surrozen Inc (SRZN) , and Consonance-HFW Acquisition Corp (CHFW.U) .
Click here to see the complete history of Christopher Y Chai’s form 4 insider trades.
Insider Ownership Summary of Christopher Y Chai
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
PRNB | Principia Biopharma Inc | 2020-09-28 | Chief Financial Officer |
SRZN | Surrozen Inc | 2021-08-11 | director |
CHFW.U | Consonance-HFW Acquisition Corp | 2021-08-11 | director |
Christopher Y Chai Latest Holdings Summary
Christopher Y Chai currently owns a total of 1 stock. Christopher Y Chai owns 6,841 shares of Principia Biopharma Inc (PRNB) as of August 18, 2020, with a value of $684,442.
Latest Holdings of Christopher Y Chai
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
PRNB | Principia Biopharma Inc | 2020-08-18 | 6,841 | 100.05 | 684,442 |
Holding Weightings of Christopher Y Chai
Christopher Y Chai Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher Y Chai has made a total of 3 transactions in Principia Biopharma Inc (PRNB) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Principia Biopharma Inc is the sale of 7,500 shares on August 18, 2020, which brought Christopher Y Chai around $745,275.
Insider Trading History of Christopher Y Chai
- 1
Christopher Y Chai Trading Performance
Christopher Y Chai Ownership Network
Christopher Y Chai Owned Company Details
What does Principia Biopharma Inc do?
Who are the key executives at Principia Biopharma Inc?
Christopher Y Chai is the Chief Financial Officer of Principia Biopharma Inc. Other key executives at Principia Biopharma Inc include Chief Medical Officer Dolca Thomas , Chief Development Officer Stefani Wolff , and Chief Scientific Officer David M Goldstein .
Principia Biopharma Inc (PRNB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Principia Biopharma Inc (PRNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Principia Biopharma Inc (PRNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Principia Biopharma Inc (PRNB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Principia Biopharma Inc Insider Transactions
Christopher Y Chai Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher Y Chai. You might contact Christopher Y Chai via mailing address: 2400 Bayshore Parkway, Suite 200, Mountain View Ca 94043.